All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BIONDVAX PHARMACEUTICALS LTD. Last Reported: 6/30/2023 Stock Symbol: BVXV

Business Address

JERUSALEM BIOPARK, 2ND FLOOR
HADASSAH EIN KEREM CAMPUS
JERUSALEM , IL 00000

Mailing Address

JERUSALEM BIOPARK, 2ND FLOOR
HADASSAH EIN KEREM CAMPUS
JERUSALEM , IL 00000
Phone Number: 972-8-9302529 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 6/30/2023 3/31/2023 12/31/2022
Cash and Cash Equivalents $7,506,000.00 $10,799,000.00 $14,075,000.00
Accounts Receivable Net Current -- -- --
Inventory -- -- --
Prepaid Expenses and Other Current Assets $138,000.00 -- $45,000.00
Total Current Assets $7,770,000.00 $11,045,000.00 $14,370,000.00
Property Plant and Equipement $10,802,000.00 $10,817,000.00 $11,245,000.00
Intangible Assets Net -- -- --
Goodwill -- -- --
Other Assets -- -- --
Total Assets $19,897,000.00 $23,292,000.00 $27,067,000.00
Accounts Payable -- -- --
Accrued Liabilities -- -- $756,000.00
Total Current Liabilities -- -- --
Long Term Debt -- -- --
Additional Paid-in Capital -- -- --
Accumulated Other Comprehensive Loss $-1,740,000.00 $-1,891,000.00 $-2,007,000.00
Accumulated Deficit $-123,112,000.00 $-119,350,000.00 $-115,835,000.00
Total Stockholders' Equity $-7,112,000.00 $-4,810,000.00 $-1,760,000.00
Controlling Interest in Subsidiaries -- -- --
Total Liabilities and Equity $19,897,000.00 $23,292,000.00 $27,067,000.00

Statement of Operations

Date 6/30/2023 3/31/2023 12/31/2022
Total Revenues -- -- --
Cost of Revenues -- -- --
Gross Profit -- -- --
Research and Development $1,454,000.00 $1,995,000.00 $5,765,000.00
Selling, General, and Administrative -- -- $5,296,000.00
Total Operating Expenses -- -- --
Loss from Operations $-5,781,000.00 $-3,186,000.00 $-11,061,000.00
Loss Before Income Taxes -- -- --
Earnings Per Share Basic $-0.01 $0.00 $-0.01
Weighted Average Shares Basic 1,351,850,046 1,295,256,604 754,076,407
Earnings Per Share Diluted $-0.01 $0.00 $-0.01
Weighted Average Shares Diluted 1,322,019,241 1,295,256,604 754,076,407
Common Stock Shares Authorized 20,000,000,000 20,000,000,000 20,000,000,000
Common Stock Shares Outstanding 1,453,970,784 1,313,623,184 989,290,784
Common Stock Value -- -- --
Common Stock Par Or Stated Value Per Share -- -- --
Payments Of Dividends Common Stock -- -- --
Preferred Stock Shares Authorized -- -- --
Preferred Stock Shares Outstanding -- -- --
Preferred Stock Value -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- --
Share Price -- -- $1.48
Copyright 2024 PursePoor.com